Status:
RECRUITING
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Lead Sponsor:
Baylor Research Institute
Conditions:
Respiratory Failure
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposu...
Detailed Description
The identification of biomarkers in a patient's blood or tissue that are specific for particular medical conditions (such as interstitial lung disease, chronic obstructive lung disease (COPD), and pos...
Eligibility Criteria
Inclusion
- All individuals aged 18 years and older
- Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years
- Individual is able to understand and sign the informed consent form
Exclusion
- Significant documented anemia (hemoglobin \<8 g/dL)
- Blood transfusions within past 3 weeks
- Active cancer (non-skin cancers)
- Enrollment against doctor recommendation
- Patient not able to provide informed consent
Key Trial Info
Start Date :
June 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04664192
Start Date
June 4 2021
End Date
December 1 2026
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Research Institute
Dallas, Texas, United States, 75246